Tracy McCarty
Conference Call Host
Replay available
BioMarin Pharmaceutical Inc. (BMRN) Q1 2025 Earnings Call
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) Q1 2025 earnings conference call, held 2025-05-01. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Alexander Hardy
President and Chief Executive Officer
Brian Mueller
Executive Vice President and Chief Financial Officer
Kristen Hubbard
Executive Vice President and Chief Commercial Officer
Greg Freiberg
Executive Vice President and Chief R&D Officer
Phil Nadeau
Analyst, TD Cowan
Jessica Phi
Analyst, JP Morgan
Paul Matthews
Analyst
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Biomarin Pharmaceutical Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.236 Good day, everyone, and welcome to the Biomarin Pharmaceutical first quarter 2025 00:00:05.236 -- 00:00:08.879 conference call. Just a reminder that this conference is being recorded. 00:00:08.879 -- 00:00:11.262 I would now like to hand things over to Ms. 00:00:11.262 -- 00:00:15.204 Tracy McCarty. Please go ahead, ma'am. 00:00:15.626 -- 00:00:20.410 Thank you, operator. To remind you, this non-confidential presentation contains forward-looking 00:00:20.410 -- 00:00:26.276 statements about the business prospects of Biomarin Pharmaceutical, Inc., including expectations 00:00:26.276 -- 00:00:30.931 regarding Biomarin's financial performance, commercial products, and potential future 00:00:30.931 -- 00:00:35.136 products in different areas of therapeutic research and development. 00:00:35.136 -- 00:00:39.922 Results may differ materially depending on the progress of Biomarin's product programs, 00:00:39.922 -- 00:00:45.448 actions of regulatory authorities, availability of capital, future actions in the pharmaceutical 00:00:45.448 -- 00:00:50.894 market, and developments by competitors. And those factors detailed in Biomarin's filings 00:00:50.894 -- 00:00:56.917 with the Securities and Exchange Commission, such as 10Q, 10K, and 8K reports. 00:00:56.917 -- 00:01:02.123 In addition, we will use non-GAAP financial measures as defined in Regulation G during 00:01:02.123 -- 00:01:07.549 the call today. These non-GAAP measures should not be considered in isolation from, as 00:01:07.549 -- 00:01:12.735 substitutes for, or superior to financial measures prepared in accordance with U.S. 00:01:12.735 -- 00:01:16.139 GAAP, and you can find the related reconciliations to U.S. 00:01:16.139 -- 00:01:21.185 GAAP in the earnings press release and e...